Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
Recommendations on data sharing in HIV drug resistance research.